This project has been flagged by a community member as inappropriate due to reason below.*

Expert Interview

Slingshot members are talking to an expert! The topic is:

A Third Perspective: Discussing the potential of sepofarsen ahead of the Illuminate trial readout in LCA10 patients

Ticker(s): PRQR

Who's the expert?

Institution: University of Miami (Bascom Palmer Eye Institute)

  • Professor of Clinical Ophthalmology Chief of Ophthalmology Section at Miami Veterans Affairs Medical Center
  • Treats 9 patients with LCA10; Involved in several gene therapy trials and has utilized Luxturna and Argus implant.
  • Research focuses on inherited retinal conditions, gene therapy, retinal prostheses, and innovative therapies.

Interview Goal
Discuss existing data with an ophthalmologist familiar with this agent and potential readthroughs to the Illuminate trial.

Are You Interested In These Questions?

Slingshot Insights Explained

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.

Reason

*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.